The hook effect: A need for constant vigilance

Annals of Clinical Biochemistry

Volumn 43, Issue 4, 2006, Pages 314-317

  Jassam, N ^a   Jones, C M ^a   Briscoe, T ^a   Horner, J H ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; PREDNISOLONE; TUMOR MARKER;

ABDOMINAL DISTENSION; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DELAYED DIAGNOSIS; DIAGNOSTIC ACCURACY; FEEDING DISORDER; FEMALE; HEMANGIOENDOTHELIOMA; HEPATOBLASTOMA; HUMAN; IMMUNOASSAY; INFANT; LIVER BIOPSY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; ULTRASOUND;

ALPHA-FETOPROTEINS; AUTOMATION; BIOPSY; CHEMISTRY, CLINICAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATOBLASTOMA; HUMANS; IMMUNOASSAY; INFANT; LIVER; LIVER NEOPLASMS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33745896812     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456306777695726     Document Type: Article

References (11)

1. Emre S, McKenna GJ. Liver tumours in children. Pediatr Transplant 2004; 8: 632-8
2. Schnater JM, Köhler SE, Lamers WH, von Schweinitz D, Aronson DC. Where do we stand with Hepatoblastoma? Cancer 2003; 98: 668-78
3. Golden CB, Feusner JH. Malignant abdominal masses in children: quick guide to evaluation diagnosis. Pediatr Clin N Am 2002; 49: 1369-92
4. Wu JT, Book L, Sudar K. Serum alpha-fetoprotein (AFP) levels in normal infants. Pediatr Res 1981; 15: 50-2
5. Brown J, Perilongo G, Shafford E, et al. Pretreatment prognostic factors for children with hepatoblastoma- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 2000; 36: 1418-25
6. Van Tornout JM, Buckley JD, Quinn JJ, et al. Timing and magnitude of decline in alpha-getoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the children's cancer group. J Clin Oncol 1997; 15: 1190-7
7. Davies JQ, de la Hall PM, Kaschula ROC, et al. Hepatoblastoma-evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases. J Pediatr Surg 2004; 39: 1321-7
8. Fernando SA, Wilson GS. Studies of the 'hook' effect in the onestep sandwich immunoassay. J Immunol Methods 1992; 151: 47-66
9. Tate J, Ward G. Interferences in Immunoassay. Clin Biochem Rev 2004; 25: 105-20
10. Sayar D, Yaniv I, Goshen Y, Cohen IJ. Treatment of alpha-fetoprotein secreting hepatoblastoma by response of serum alpha-fetoprotein levels: a new concept. Pediatric Hematol Oncol 2001; 18: 509-18
11. Sturgeon C, Hammond E, Ch'ng S-L, Soletormos G, Hayes DF. National Academy of Clinical Biochemistry (NACB) Guidelines on the use of tumour markers in the clinic. Section 2: Quality requirements for the use of tumour markers. 2005; http://www.nacb.org/